http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131867-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c672a87dd2da8b47ac01fa28081f0f9d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-471
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
filingDate 2007-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70cd88abcc3c82ec0a73b2f9016fccae
publicationDate 2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008131867-A1
titleOfInvention Method for Determining the Effectiveness of a Treatment for Preeclampsia
abstract A method for determining the effectiveness of a treatment for preeclampsia of a pregnant woman at risk for preeclampsia, the method comprising: (a) determining a first concentration of placental protein 13 (PP13) in a bodily substance of the woman obtained prior to the treatment; (b) determining a second concentration of PP13 in a bodily substance of the woman obtained after initiation of the treatment; and (c) comparing the first and second concentrations to a corresponding normal level of PP13 and, based on the comparison, determining the effectiveness of the treatment. Diagnostic kits for practicing the method are also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086368-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9488622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011124124-A1
priorityDate 2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548306-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6790625-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5198366-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136069385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128958218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Total number of triples: 45.